Case Studies
New York Updates Cannabis Packaging, Labeling, and Advertising Regulations
NEW YORK – The New York State Cannabis Control Board ...
Trump Video Fuels Cannabis Stock Surge, Yet Analysts Question Depth of Policy Shift
LOS ANGELES – A recent video posted by President Donald ...
Ex-Curaleaf Executive Files Suit Alleging Ignored Warnings on Inventory Shortfalls at Illinois Facility
LOS ANGELES – A former compliance director for Curaleaf Holdings ...
Psilocybin Study Suggests Potential for Longevity Benefits
LOS ANGELES- New preclinical research indicates that psilocybin the active psychoactive compound in psychedelic mushrooms—may significantly extend lifespan in both human cells and aged mice. Published July 8, 2025, in npj Aging, the study found ...
Challenges Emerge Over Kentucky’s Medical Cannabis License Lottery
LOS ANGELES- A coalition of Kentucky-based businesses has filed legal proceedings challenging the fairness and constitutionality of the state’s April 2024 medical cannabis license lottery. The lawsuit, lodged in Jefferson Circuit Court on June 27, ...
Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target
LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on atai Life Sciences N.V. (NASDAQ: ATAI), maintaining a price target of $8 following the release of positive Phase 2b results for BPL-003, the company’s investigational ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Why Bob Hoban Is Defending Steve DeAngelo—And What It Reveals About Cannabis Policy
LOS ANGELES- In cannabis industry discourse, facts can be overshadowed by simplified narratives. One such claim—widely circulated in trade circles—is that Steve DeAngelo, founder of Harborside and a prominent figure in the legalization movement, was ...
DEA Grants Import Permit for Psilocybin Truffles to Red Light Holland and Irvine Labs
LOS ANGELES- Red Light Holland Corp, an Ontario-based producer of psilocybin truffles, announced that its U.S. partner, Irvine Labs, has received a Controlled Substances Import Permit from the Drug Enforcement Administration (DEA). This authorization allows ...
Glass House Brands Proposes Long-Term Incentive Plan Tied to Share Price Performance
LOS ANGELES- Glass House Brands Inc. a vertically integrated cannabis company, has announced the mailing of its management information circular to shareholders ahead of its annual and special meeting scheduled for June 20, 2025. At ...
Psilocybin Study Suggests Potential for Longevity Benefits
LOS ANGELES- New preclinical research indicates that psilocybin the active psychoactive compound in psychedelic mushrooms—may significantly extend lifespan in both human cells and aged mice. Published July 8, 2025, in npj Aging, the study found ...
Challenges Emerge Over Kentucky’s Medical Cannabis License Lottery
LOS ANGELES- A coalition of Kentucky-based businesses has filed legal proceedings challenging the fairness and constitutionality of the state’s April 2024 medical cannabis license lottery. The lawsuit, lodged in Jefferson Circuit Court on June 27, ...
Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target
LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on atai Life Sciences N.V. (NASDAQ: ATAI), maintaining a price target of $8 following the release of positive Phase 2b results for BPL-003, the company’s investigational ...
